PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver neoplasms |
| Phenotype | C0023890|cirrhosis |
| Sentences | 6 |
| PubMedID- 24935302 | Patient data in our unit were collected to evaluate the impact of liver tumor on outcomes in patients with hbv-related cirrhosis who underwent lt. |
| PubMedID- 22945816 | Emphasis lies on new data related to contrast-ultrasound (sulphur hexafluoride sonovue(r)) which allows a dynamic analysis of liver perfusion and hence improved characterization of focal liver lesions, such as metastases of extrahepatic tumors, regenerative nodules in patients with liver cirrhosis, focal nodular hyperplasia, hepatocellular carcinoma, liver hemangioma, liver adenoma and or focal hypo-respectively hypersteatosis. |
| PubMedID- 21518826 | Quantitative measurement and comparison of seven bile acids among benign liver tumor patients with liver cirrhosis and hepatitis, hcc patients with liver cirrhosis and hepatitis, hcc patients without liver cirrhosis and hepatitis, and healthy controls revealed that the abnormal levels of glycochenodeoxycholic acid, glycocholic acid, taurocholic acid, and chenodeoxycholic acid are associated with liver cirrhosis and hepatitis. |
| PubMedID- 21693256 | Objective: the aim of this study was to determine the accuracy of superparamagnetic iron oxide (spio)-enhanced magnetic resonance imaging (mri) in the detection of liver tumors in patients with liver cirrhosis before liver transplantation (lt). |
| PubMedID- 24136649 | We also assessed the advantages of evaluating the sg compared with recently reported transit time analyses using a contrast agent to determine the hvat, hv–ha interval time and hv–pv interval time in diagnosing compensated cirrhosis in patients with liver tumors. |
| PubMedID- 19464131 | Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced us: a pilot study. |
Page: 1